ProCE Banner Activity

Individualizing the Care of Patients with CLL/SLL: Key Variables in Treatment-Decision Making


Download these slides from a live symposium at ASCO 2023 to learn more about how to personalize the care of patients with CLL/SLL

Released: June 02, 2023



Brian Hill

Brian Hill, MD, PhD

Director, Lymphoid Malignancies Program
Staff Physician, Department of Hematology and Medical Oncology
Taussig Cancer Institute
Cleveland Clinic
Cleveland, Ohio

Provided by

Provided by the National Comprehensive Cancer Network, in partnership with Clinical Care Options, LLC

ProCE Banner


Supported by educational grants from AstraZeneca, BeiGene Ltd, and Lilly. Supported by independent educational grants from Merck & Co., Inc., Rahway, NJ, USA, and Pharmacyclics, an AbbVie Company and Janssen Biotech, Inc.


BeiGene, Ltd.

Janssen Biotech, Inc.


Merck Sharp & Dohme Corp.

Pharmacyclics LLC, an AbbVie Company


Clinical Care Options, LLC

ProCE Banner